STRS Ohio’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,670
| Closed | -$117K | – | 2240 |
|
|
2025
Q1 | $117K | Hold |
20,670
| – | – | ﹤0.01% | 1634 |
|
|
2024
Q4 | $436K | Buy |
20,670
+4,370
| +27% | +$100K | ﹤0.01% | 1256 |
|
|
2024
Q3 | $438K | Buy |
16,300
+900
| +6% | +$26.5K | ﹤0.01% | 1321 |
|
|
2024
Q2 | $439K | Buy |
15,400
+3,880
| +34% | +$136K | ﹤0.01% | 1316 |
|
|
2024
Q1 | $488K | Buy |
11,520
+1,040
| +10% | +$46.8K | ﹤0.01% | 1281 |
|
|
2023
Q4 | $560K | Sell |
10,480
-2,060
| -16% | -$93K | ﹤0.01% | 1221 |
|
|
2023
Q3 | $539K | Buy |
12,540
+3,390
| +37% | +$156K | ﹤0.01% | 1216 |
|
|
2023
Q2 | $502K | Buy |
+9,150
| New | +$502K | ﹤0.01% | 1285 |
|
|
2022
Q2 | – | Sell |
-11,400
| Closed | -$707K | – | 2145 |
|
|
2022
Q1 | $707K | Buy |
11,400
+940
| +9% | +$55.6K | ﹤0.01% | 1266 |
|
|
2021
Q4 | $737K | Buy |
10,460
+720
| +7% | +$51.2K | ﹤0.01% | 1328 |
|
|
2021
Q3 | $679K | Sell |
9,740
-810
| -8% | -$64.5K | ﹤0.01% | 1380 |
|
|
2021
Q2 | $878K | Sell |
10,550
-540
| -5% | -$38.2K | ﹤0.01% | 1248 |
|
|
2021
Q1 | $605K | Sell |
11,090
-3,790
| -25% | -$184K | ﹤0.01% | 1494 |
|
|
2020
Q4 | $638K | Sell |
14,880
-1,090
| -7% | -$40.7K | ﹤0.01% | 1346 |
|
|
2020
Q3 | $480K | Buy |
15,970
+460
| +3% | +$15.5K | ﹤0.01% | 1358 |
|
|
2020
Q2 | $480K | Buy |
+15,510
| New | +$418K | ﹤0.01% | 1332 |
|
|
2019
Q2 | – | Sell |
-14,610
| Closed | -$428K | – | 2150 |
|
|
2019
Q1 | $629K | Hold |
14,610
| – | – | ﹤0.01% | 1101 |
|
|
2018
Q4 | $464K | Buy |
14,610
+4,942
| +51% | +$195K | ﹤0.01% | 1291 |
|
|
2018
Q3 | $507K | Buy |
9,668
+1,728
| +22% | +$97K | ﹤0.01% | 1376 |
|
|
2018
Q2 | $424K | Buy |
+7,940
| New | +$407K | ﹤0.01% | 1448 |
|
|
2016
Q3 | – | Sell |
-8,884
| Closed | -$254K | – | 1927 |
|
|
2016
Q2 | $254K | Sell |
8,884
-8,746
| -50% | -$278K | ﹤0.01% | 1499 |
|
|
2016
Q1 | $532K | Hold |
17,630
| – | – | ﹤0.01% | 1230 |
|
|
2015
Q4 | $611K | Buy |
17,630
+3,607
| +26% | +$123K | ﹤0.01% | 1175 |
|
|
2015
Q3 | $530K | Buy |
14,023
+2,633
| +23% | +$123K | ﹤0.01% | 1247 |
|
|
2015
Q2 | $649K | Buy |
+11,390
| New | +$648K | ﹤0.01% | 1231 |
|
|
2014
Q2 | – | Sell |
-13,880
| Closed | -$583K | – | 1721 |
|
|
2014
Q1 | $658K | Hold |
13,880
| – | – | ﹤0.01% | 1024 |
|
|
2013
Q4 | $652K | Sell |
13,880
-5,140
| -27% | -$225K | ﹤0.01% | 1076 |
|
|
2013
Q3 | $758K | Hold |
19,020
| – | – | ﹤0.01% | 1036 |
|
|
2013
Q2 | $682K | Buy |
+19,020
| New | +$728K | ﹤0.01% | 1143 |
|
Other funds holding HBIO
AE
HP
GIM
MIM
STRS Ohio's HBIO Position: Q2 2025 in Review
STRS Ohio sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 20,670 shares — an estimated $117K sold.
STRS Ohio first reported a position in HBIO in Q2 2013 and held it in 29 quarters. The position peaked at $878K in Q2 2021. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.
- STRS Ohio reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
- STRS Ohio sold 20,670 Harvard Bioscience shares in Q2 2025, an estimated $117K.
- STRS Ohio first reported a position in Harvard Bioscience in Q2 2013 and held it in 29 quarters.
- STRS Ohio's Harvard Bioscience position peaked at $878K in Q2 2021.
- 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.